Par panel finds deficiencies in drugs procurement by CGHS

Image
Press Trust of India New Delhi
Last Updated : Aug 13 2015 | 8:07 PM IST
A parliamentary panel has found several deficiencies in procurement of allopathic drugs for Central Government Health Scheme (CGHS) causing "significant" financial burden and has asked the Health Ministry to plug loopholes and take corrective measures and strengthen its internal control system.
The Public Accounts Committee (PAC) for the Union Health Ministry on "procurement of allopathic drugs in CGHS" in its 16 recommendations has also asked the Ministry to furnish particulars of those CGHS Wellness centres which are performing well and those that are lagging behind.
"The committee find that there have been several deficiencies in the management of pharmaceutical procurement procedure for procurement of allopathic drugs for CGHS.
"The committee finds that 71 per cent of drugs procured consisted of drugs outside the formulary (of CGHS) despite the fact that prices of drugs in the formulary are comparatively lower," the PAC chaired by former Union Minister K V Thomas said in its report said.
Noting that CGHS resorted to procurement of higher priced branded drugs despite the availability of low cost brands, the PAC said that this has cause "significant additional" financial burden to the exchequer while high incidence of local purchase of drugs and irregularities has been reported in such procurements.
The report said that prescription patterns of the doctors is also leading to high incidence of local purchase of drugs. It said despite having a code of ethics in Indian Medical Council Rules introduced in 2009 forbidding doctors from accepting any gift, hospitality, trips to foreign and domestic destinations from health care industry, there is no let up to this "evil" practice.
"The committee urges the Health Ministry to plug the loopholes and take timely corrective action...And recommend that the Ministry should strengthen their internal control system to check irregularities in procurement process and ensure procurement of good quality medicines at affordable prices in accordance with the cannons of financial propriety," it said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 13 2015 | 8:07 PM IST

Next Story